HRP20010332B1 - Farmaceutski pripravak moksifloksacina - Google Patents

Farmaceutski pripravak moksifloksacina

Info

Publication number: HRP20010332B1
Authority: HR; Croatia
Prior art keywords: moxifloxacin; pharmaceutical preparation; disintegrant; hydrate; lactose
Prior art date: 1998-11-10

Application number

HR20010332A

Other languages

English (en)

Croatian (hr)

Inventor

Bosche Patrick

Friedrich Mahler Hans

Weisemann Claus

Original Assignee

Bayer Schering Pharma Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-10

Filing date

1999-10-29

Publication date

2011-01-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7889824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20010332(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-10-29 Application filed by Bayer Schering Pharma Aktiengesellschaft filed Critical Bayer Schering Pharma Aktiengesellschaft

2002-06-30 Publication of HRP20010332A2 publication Critical patent/HRP20010332A2/hr

2011-01-31 Publication of HRP20010332B1 publication Critical patent/HRP20010332B1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

HR20010332A 1998-11-10 1999-10-29 Farmaceutski pripravak moksifloksacina HRP20010332B1 (hr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19855758		1998-11-10
PCT/EP1999/008230 WO2000027398A1 (de)	1998-11-10	1999-10-29	Pharmazeutische zubereitung von moxifloxacin

Publications (2)

Publication Number	Publication Date
HRP20010332A2 HRP20010332A2 (en)	2002-06-30
HRP20010332B1 true HRP20010332B1 (hr)	2011-01-31

Family

ID=7889824

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20010332A HRP20010332B1 (hr)	1998-11-10	1999-10-29	Farmaceutski pripravak moksifloksacina

Country Status (41)

Country	Link
US (1)	US6610327B1 (cs)
EP (1)	EP1128831B1 (cs)
JP (1)	JP4809978B2 (cs)
KR (1)	KR100650489B1 (cs)
CN (1)	CN1149993C (cs)
AR (1)	AR021074A1 (cs)
AT (1)	ATE279193T1 (cs)
AU (1)	AU745282B2 (cs)
BG (1)	BG64974B1 (cs)
BR (2)	BR9915208A (cs)
CA (1)	CA2349161C (cs)
CO (1)	CO5070571A1 (cs)
CU (1)	CU23260B7 (cs)
CZ (1)	CZ292069B6 (cs)
DE (1)	DE59910858D1 (cs)
DK (1)	DK1128831T3 (cs)
EE (1)	EE04418B1 (cs)
ES (1)	ES2229786T3 (cs)
HK (1)	HK1042245B (cs)
HN (1)	HN1999000183A (cs)
HR (1)	HRP20010332B1 (cs)
HU (1)	HU229065B1 (cs)
ID (1)	ID29089A (cs)
IL (2)	IL142642A0 (cs)
MA (1)	MA26757A1 (cs)
MY (1)	MY121114A (cs)
NO (1)	NO319342B1 (cs)
NZ (1)	NZ511554A (cs)
PE (1)	PE20001304A1 (cs)
PL (1)	PL194020B1 (cs)
PT (1)	PT1128831E (cs)
RU (1)	RU2230555C9 (cs)
SI (1)	SI1128831T1 (cs)
SK (1)	SK283936B6 (cs)
SV (1)	SV1999000194A (cs)
TR (1)	TR200101310T2 (cs)
TW (1)	TW580388B (cs)
UA (1)	UA72483C2 (cs)
UY (1)	UY25792A1 (cs)
WO (1)	WO2000027398A1 (cs)
ZA (1)	ZA200103141B (cs)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19937116A1 (de) *	1999-08-06	2001-02-08	Bayer Ag	Moxifloxacin Kochsalzformulierung
GB0209265D0 (en)	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
EP1663226A1 (en) *	2003-09-03	2006-06-07	Ranbaxy Laboratories Limited	Pharmaceutical compositions of moxifloxacin and processes for their preparation
CN1330306C (zh) *	2004-08-11	2007-08-08	深圳市天一时科技开发有限公司	莫西沙星明胶胶囊剂及其制备方法
WO2006015545A1 (fr) *	2004-08-11	2006-02-16	Shenzhen Tys R & D Co., Ltd.	Capsule de gelatine de moxifloxacin et procede pour sa preparation
CN100363001C (zh) *	2005-09-21	2008-01-23	深圳市天一时科技开发有限公司	一种莫西沙星胶囊剂及其制备方法
WO2007033522A1 (fr) *	2005-09-21	2007-03-29	Shenzhen Tys R & D Co., Ltd.	Formulation de gélule contenant de la moxifloxacine et son procédé de préparation
WO2007033515A1 (fr) *	2005-09-21	2007-03-29	Shenzhen Tys R & D Co., Ltd.	Formulation orale contenant de la moxifloxacine et son procédé de préparation
EA201170545A1 (ru) *	2008-10-09	2012-01-30	Абды Ибрахым Иладж Санайи Ве Тыджарет Аноным Сыркеты	Применение органических растворителей в способе влажного гранулирования моксифлоксацина
EA028676B1 (ru)	2008-12-08	2017-12-29	Рациофарм Гмбх	Спрессованный моксифлоксацин
TR200907227A2 (tr) *	2009-09-18	2011-04-21	Bi̇lgi̇ç Mahmut	Çözünürlüğü yüksek stabil mikronize granüller.
CN101890169B (zh) *	2009-11-16	2013-09-11	江苏亚邦强生药业有限公司	莫西沙星口服制剂及其制备方法
WO2011086577A2 (en) *	2010-01-12	2011-07-21	Msn Laboratories Limited	Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
CN102247313A (zh) *	2010-06-11	2011-11-23	北京润德康医药技术有限公司	一种以莫西沙星为活性成分的口服缓释固体制剂
CN102247314A (zh) *	2011-01-12	2011-11-23	北京润德康医药技术有限公司	一种以莫西沙星为活性成分的口服固体制剂
EP2510929A1 (en) *	2011-04-11	2012-10-17	Innocoll Technologies Limited	Methods for treating bacterial infection
MX2011004759A (es)	2011-05-04	2012-11-21	Senosiain S A De C V Lab	Nuevas formas solidas de antibioticos.
RU2466718C1 (ru) *	2011-10-14	2012-11-20	Закрытое акционерное общество "Брынцалов-А"	Фармацевтический препарат моксифлоксацина
US9358261B2 (en)	2011-10-25	2016-06-07	U.S. Phytotherapy, Inc.	Additional artemisinin and berberine compositions and methods of making
US9675582B2 (en)	2011-10-25	2017-06-13	U.S. Phytotherapy, Inc.	Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
CA2853701A1 (en)	2011-10-25	2013-05-02	U.S. Phytotherapy, Inc.	Artemisinin and berberine compositions and methods of making
WO2013063271A1 (en) *	2011-10-25	2013-05-02	U.S. Phytotherapy, Inc.	Artemisinin and berberine compositions and methods of making
WO2013081044A1 (ja) *	2011-11-30	2013-06-06	富山化学工業株式会社	１－シクロプロピル－８－（ジフルオロメトキシ）－７－［（１ｒ）－１－メチル－２，３－ジヒドロ－１ｈ－イソインドール－５－イル］－４－オキソ－１，４－ジヒドロキノリン－３－カルボン酸のメタンスルホン酸塩水和物含有錠剤
BRPI1106900A2 (pt)	2011-12-26	2013-11-05	Ems Sa	Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
CN102525982A (zh) *	2012-02-21	2012-07-04	天津市汉康医药生物技术有限公司	一种稳定的盐酸莫西沙星药物组合物
CN102600093B (zh) *	2012-04-11	2013-06-05	南京优科生物医药有限公司	一种莫西沙星片剂及其制备方法
FR2992218B1 (fr)	2012-06-22	2015-01-23	Rivopharm Sa	Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN103768063B (zh) *	2012-10-19	2016-04-20	深圳信立泰药业股份有限公司	一种盐酸莫西沙星药物组合物及其制备方法
RU2561037C2 (ru) *	2013-02-07	2015-08-20	Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН")	Антибактериальная фармацевтическая композиция и способ ее получения
WO2015093669A1 (ko) *	2013-12-20	2015-06-25	씨제이헬스케어 주식회사	목시플록사신 수성 제형 및 이의 제조방법
RU2558932C1 (ru) *	2014-05-22	2015-08-10	Открытое Акционерное Общество "Татхимфармпрепараты"	Фармацевтическая композиция моксифлоксацина и способ ее приготовления

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0350733A2 (de) *	1988-07-15	1990-01-17	Bayer Ag	7-(1-Pyrrolidinyl)-3-chinolon- und -naphthyridoncarbon-säure-Derivate, Verfahren zu ihrer Herstellung sowie substituierte mono-und bicyclische Pyrrolidinderivate als Zwischenprodukte zu ihrer Herstellung, und sie enthaltende antibakterielle Mittel und Futterzusatzstoffe
DE19546249A1 (de) *	1995-12-12	1997-06-19	Bayer Ag	Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3601566A1 (de) *	1986-01-21	1987-07-23	Bayer Ag	Pharmazeutische zubereitungen von ciprofloxacin
US5286754A (en)	1986-01-21	1994-02-15	Bayer Aktiengesellschaft	Pharmaceutical formulations of ciprofloxacin
WO1989003681A1 (en) *	1987-10-19	1989-05-05	Pfizer Inc.	Substituted tetralins, chromans and related compounds in the treatment of asthma
JPH01175936A (ja) *	1987-12-28	1989-07-12	Kyorin Pharmaceut Co Ltd	６．８−ジフルオロ−１−（２−フルオロエチル）−１，４−ジヒドロ−７−（４−メチル−１−ピペラジニル）−４−オキソ−３−キノリンカルボン酸を有効成分とする錠剤
EP0449445A3 (en) *	1990-03-27	1993-08-25	Pfizer Inc.	Preparation of beta-ketoesters useful in preparing quinolone antibiotics
TW209865B (cs) *	1992-01-10	1993-07-21	Bayer Ag
PA8466701A1 (es) *	1998-01-21	2000-09-29	Pfizer Prod Inc	Comprimido de mesilato de trovafloxacino

1999
- 1999-10-29 BR BR9915208-8A patent/BR9915208A/pt not_active IP Right Cessation
- 1999-10-29 EP EP99955906A patent/EP1128831B1/de not_active Expired - Lifetime
- 1999-10-29 DK DK99955906T patent/DK1128831T3/da active
- 1999-10-29 JP JP2000580627A patent/JP4809978B2/ja not_active Expired - Lifetime
- 1999-10-29 DE DE1999510858 patent/DE59910858D1/de not_active Expired - Lifetime
- 1999-10-29 ID IDW00200101040A patent/ID29089A/id unknown
- 1999-10-29 ES ES99955906T patent/ES2229786T3/es not_active Expired - Lifetime
- 1999-10-29 TR TR2001/01310T patent/TR200101310T2/xx unknown
- 1999-10-29 SK SK610-2001A patent/SK283936B6/sk not_active IP Right Cessation
- 1999-10-29 HR HR20010332A patent/HRP20010332B1/xx not_active IP Right Cessation
- 1999-10-29 HU HU0104762A patent/HU229065B1/hu unknown
- 1999-10-29 SI SI9930706T patent/SI1128831T1/xx unknown
- 1999-10-29 AT AT99955906T patent/ATE279193T1/de active
- 1999-10-29 KR KR1020017005833A patent/KR100650489B1/ko not_active Expired - Lifetime
- 1999-10-29 WO PCT/EP1999/008230 patent/WO2000027398A1/de active IP Right Grant
- 1999-10-29 CZ CZ20011652A patent/CZ292069B6/cs not_active IP Right Cessation
- 1999-10-29 EE EEP200100259A patent/EE04418B1/xx unknown
- 1999-10-29 NZ NZ511554A patent/NZ511554A/en not_active IP Right Cessation
- 1999-10-29 PT PT99955906T patent/PT1128831E/pt unknown
- 1999-10-29 US US09/830,770 patent/US6610327B1/en not_active Expired - Lifetime
- 1999-10-29 AU AU12674/00A patent/AU745282B2/en not_active Expired
- 1999-10-29 HK HK02104010.6A patent/HK1042245B/zh not_active IP Right Cessation
- 1999-10-29 BR BRPI9915208-8 patent/BRPI9915208B8/pt unknown
- 1999-10-29 RU RU2001116096/15A patent/RU2230555C9/ru active
- 1999-10-29 PL PL99348112A patent/PL194020B1/pl unknown
- 1999-10-29 CA CA002349161A patent/CA2349161C/en not_active Expired - Lifetime
- 1999-10-29 IL IL14264299A patent/IL142642A0/xx active IP Right Grant
- 1999-10-29 UA UA2001063872A patent/UA72483C2/uk unknown
- 1999-10-29 CN CNB998131245A patent/CN1149993C/zh not_active Expired - Lifetime
- 1999-11-01 HN HN1999000183A patent/HN1999000183A/es unknown
- 1999-11-03 AR ARP990105567A patent/AR021074A1/es active IP Right Grant
- 1999-11-04 TW TW088119183A patent/TW580388B/zh not_active IP Right Cessation
- 1999-11-05 MY MYPI99004825A patent/MY121114A/en unknown
- 1999-11-08 UY UY25792A patent/UY25792A1/es not_active Application Discontinuation
- 1999-11-09 CO CO99070667A patent/CO5070571A1/es unknown
- 1999-11-09 PE PE1999001134A patent/PE20001304A1/es not_active IP Right Cessation
- 1999-11-10 SV SV1999000194A patent/SV1999000194A/es active IP Right Grant
2001
- 2001-04-17 IL IL142642A patent/IL142642A/en not_active IP Right Cessation
- 2001-04-18 ZA ZA200103141A patent/ZA200103141B/en unknown
- 2001-04-20 BG BG105459A patent/BG64974B1/bg unknown
- 2001-05-07 NO NO20012248A patent/NO319342B1/no not_active IP Right Cessation
- 2001-05-10 CU CU20010114A patent/CU23260B7/es unknown
- 2001-05-10 MA MA26189A patent/MA26757A1/fr unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0350733A2 (de) *	1988-07-15	1990-01-17	Bayer Ag	7-(1-Pyrrolidinyl)-3-chinolon- und -naphthyridoncarbon-säure-Derivate, Verfahren zu ihrer Herstellung sowie substituierte mono-und bicyclische Pyrrolidinderivate als Zwischenprodukte zu ihrer Herstellung, und sie enthaltende antibakterielle Mittel und Futterzusatzstoffe
DE19546249A1 (de) *	1995-12-12	1997-06-19	Bayer Ag	Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number	Publication date
PL348112A1 (en)	2002-05-06
CU23260B7 (es)	2008-01-24
IL142642A (en)	2006-10-05
KR100650489B1 (ko)	2006-11-28
UA72483C2 (en)	2005-03-15
AU745282B2 (en)	2002-03-21
SK283936B6 (sk)	2004-05-04
HK1042245B (zh)	2005-03-11
DK1128831T3 (da)	2005-01-17
TW580388B (en)	2004-03-21
NO20012248D0 (no)	2001-05-07
AR021074A1 (es)	2002-06-12
PL194020B1 (pl)	2007-04-30
ZA200103141B (en)	2002-05-07
KR20010089424A (ko)	2001-10-06
MA26757A1 (fr)	2004-12-20
BRPI9915208B8 (pt)	2021-07-06
ID29089A (id)	2001-07-26
CA2349161A1 (en)	2000-05-18
BRPI9915208A (pt)	2001-07-31
NO319342B1 (no)	2005-07-18
JP2002529415A (ja)	2002-09-10
HU229065B1 (en)	2013-07-29
NO20012248L (no)	2001-06-06
PT1128831E (pt)	2005-01-31
WO2000027398A1 (de)	2000-05-18
BRPI9915208B1 (pt)	2011-11-01
CN1325306A (zh)	2001-12-05
CN1149993C (zh)	2004-05-19
CZ20011652A3 (cs)	2001-08-15
JP4809978B2 (ja)	2011-11-09
NZ511554A (en)	2003-07-25
EP1128831A1 (de)	2001-09-05
SK6102001A3 (en)	2001-12-03
SV1999000194A (es)	2000-10-16
RU2230555C9 (ru)	2006-02-27
EE04418B1 (et)	2005-02-15
RU2230555C2 (ru)	2004-06-20
HRP20010332A2 (en)	2002-06-30
CA2349161C (en)	2008-01-29
UY25792A1 (es)	2001-08-27
EP1128831B1 (de)	2004-10-13
TR200101310T2 (tr)	2001-10-22
AU1267400A (en)	2000-05-29
BG64974B1 (bg)	2006-11-30
BR9915208A (pt)	2001-07-31
HUP0104762A2 (hu)	2002-05-29
ES2229786T3 (es)	2005-04-16
HUP0104762A3 (en)	2002-10-28
MY121114A (en)	2005-12-30
ATE279193T1 (de)	2004-10-15
BG105459A (en)	2001-12-29
CO5070571A1 (es)	2001-08-28
IL142642A0 (en)	2002-03-10
HK1042245A1 (en)	2002-08-09
SI1128831T1 (en)	2005-04-30
HN1999000183A (es)	1999-11-01
US6610327B1 (en)	2003-08-26
EE200100259A (et)	2002-12-16
DE59910858D1 (de)	2004-11-18
PE20001304A1 (es)	2000-12-30
CZ292069B6 (cs)	2003-07-16

Publication	Publication Date	Title
HRP20010332B1 (hr)	2011-01-31	Farmaceutski pripravak moksifloksacina
FR2805818B1 (fr)	2002-04-26	Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
HUP0300207A3 (en)	2005-07-28	1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
EE9700363A (et)	1998-06-15	Uus anesteseeriva toimega farmatseutiline segu
EE04275B1 (et)	2004-04-15	Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
HUP0200312A3 (en)	2002-12-28	Substituted 2-phenylbenzimidazoles, pharmaceutical compositions containing them, the production thereof and their use
HUP0401567A3 (en)	2005-06-28	Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
EE200000468A (et)	2002-04-15	Ühendid, nende kasutamine ja farmatseutiline kompositsioon
HUP0100101A3 (en)	2001-12-28	Prostaglandin agonists, pharmaceutical compositions comprising thereof and their use
DZ2964A1 (fr)	2004-03-15	Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
FR2775596B1 (fr)	2004-12-24	Nouvelles compositions pharmaceutiques
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
FR2783246B1 (fr)	2000-11-17	Derives d'azetidine, leur preparation et les medicaments les contenant
HUP0303148A3 (en)	2009-08-28	4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation
HUP0203542A3 (en)	2003-07-28	3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
EE9500064A (et)	1996-06-17	Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
HUP0402003A3 (en)	2005-06-28	Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
HUP0101333A3 (en)	2002-12-28	Diazepan derivatives and their salts, pharmaceutical compositions containing the same
HUP0102766A3 (en)	2002-11-28	Aminomethylcarboxylic acid derivatives, their pharmaceutical use and pharmaceutical compositions comprising them
HUP0400246A3 (en)	2009-12-28	1,2,4-trioxolane antimalarial pharmaceutical compositions and process for their preparation and use
RS49723B (sr)	2007-12-31	Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
HUP0401403A3 (en)	2005-11-28	2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0400179A3 (en)	2004-10-28	2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
EE200200342A (et)	2003-06-16	Asendatud 8-arüülkinoliinid, nende kasutamine, farmatseutiline kompositsioon ja prekursorühend
EE200200281A (et)	2003-06-16	Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks

Legal Events

Date	Code	Title	Description
2002-06-30	A1OB	Publication of a patent application
2002-09-24	ARAI	Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
2004-10-13	PPPP	Transfer of rights	Owner name: BAYER HEALTHCARE AG, DE
2010-04-21	PPPP	Transfer of rights	Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE
2011-01-31	B1PR	Patent granted
2013-06-28	PNAN	Change of the applicant name, address/residence	Owner name: BAYER PHARMA AG, DE
2013-09-05	PPPP	Transfer of rights	Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE
2018-10-19	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20181005 Year of fee payment: 20
2019-10-30	PB20	Patent expired after termination of 20 years	Effective date: 20191029